Ascendis Pharma A/S

(NASDAQ:ASND)

Latest On Ascendis Pharma A/S (ASND):

Date/Time Type Description Signal Details
2023-05-08 18:47 ESTNewsAscendis Pharma added to Wedbush's best ideas listN/A
2023-05-02 17:38 ESTNewsAscendis Pharma Q1 Earnings: Skytrofa Soars, PTH Hurdles Yet To ClearN/A
2023-05-01 17:06 ESTNewsAscendis' TransCon gets FDA rejection but company hopeful as no new trials requestedN/A
2023-04-28 02:05 ESTNewsAscendis Pharma A/S (ASND) Q1 2023 Earnings Call TranscriptN/A
2023-04-27 01:02 ESTNewsAscendis Pharma Q1 2023 Earnings PreviewN/A
2023-04-20 16:46 ESTNewsAscendis Pharma: A Promising Diversification PlayN/A
2023-04-17 01:29 ESTNewsAscendis Pharma: Recent FDA Setbacks Present A Buying OpportunityN/A
2023-04-06 23:12 ESTNewsAscendis Pharma: Is Dip On TransCon Application A Buy Opportunity?N/A
2023-04-03 14:24 ESTNewsAscendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon applicationN/A
2023-04-03 14:24 ESTNewsAscendis downgraded at Credit Suisse on deficiencies in drug applicationN/A
2023-02-17 11:10 ESTNewsAscendis Pharma A/S (ASND) Q4 2022 Earnings Call TranscriptN/A
2023-02-16 22:05 ESTNewsAscendis Pharma GAAP EPS of -€10.40, revenue of €51.17MN/A
2023-02-15 19:21 ESTNewsAscendis Pharma FY 2022 Earnings PreviewN/A
2023-01-27 16:41 ESTNewsAscendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral RatingN/A
2023-01-19 02:12 ESTNewsAscendis Pharma: Group's Best Nearby Capital Gain Price-Position StockN/A
2022-11-17 14:37 ESTNewsAscendis, Visen' once-weekly growth hormone drug beats daily hGH in Chinese patients in trialN/A
2022-11-14 19:34 ESTNewsAscendis falls on Phase 2 data for achondroplasia candidateN/A
2022-11-05 05:43 ESTNewsAscendis Pharma A/S (ASND) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 12:46 ESTNewsAscendis Pharma: Translating Valuable IP Into A Profitable BusinessN/A
2022-11-03 02:59 ESTNewsAscendis Pharma GAAP EPS of -€3.03, revenue of €15.29MN/A
2022-11-01 19:43 ESTNewsAscendis Pharma Q3 2022 Earnings PreviewN/A
2022-11-01 03:36 ESTNewsAscendis parathyroid hormone therapy goes under FDA priority reviewN/A
2022-09-16 02:59 ESTNewsAscendis Pharma: TransCon CNP Data Coming Q4N/A
2022-08-31 23:18 ESTNewsAscendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTHN/A
2022-08-11 20:08 ESTNewsAscendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug SkytrofaN/A
2022-08-11 03:38 ESTNewsAscendis Pharma GAAP EPS of -€1.46 beats by €0.69, revenue of €6.16B beats by $6.15BN/A
2022-08-11 03:37 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 09:43 ESTNewsAscendis Pharma Q2 2022 Earnings PreviewN/A
2022-08-04 05:34 ESTNewsAscendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain ProspectN/A
2022-05-23 09:02 ESTNewsAscendis, Visen' TransCon hGH meets main goal in growth hormone deficiency China trial in childrenN/A
2022-05-13 04:45 ESTNewsAscendis Pharma slides after Street analysts cut price target over SKYTROFA revenue missN/A
2022-05-12 09:00 ESTNewsAscendis Pharma GAAP EPS of -€2.21 misses by €0.05, revenue of €6.83M beats by €1.98MN/A
2022-05-12 09:00 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 19:27 ESTNewsAscendis Pharma Q1 2022 Earnings PreviewN/A
2022-05-09 22:24 ESTNewsAscendis Pharma: Biotech Bear Provides Attractive Entry PointN/A
2022-04-29 17:39 ESTNewsAscendis: Institutional Buying Activity Now Seen As Good Value By Market-MakersN/A
2022-03-25 08:03 ESTNewsAscendis Pharma prices $500.0M convertible senior notes offeringN/A
2022-03-23 22:32 ESTNewsAscendis Pharma slides on offering of $500M convertible senior notesN/A
2022-03-16 20:02 ESTNewsAscendis posts biggest intraday gain in six months as BofA upgrades on trial resultsN/A
2022-03-14 20:55 ESTNewsAscendis Pharma TransCon PTH for hypoparathyroidism meets main goal in phase 3 trialN/A
2022-03-03 04:55 ESTNewsAscendis Pharma GAAP EPS of $7.00 beats by €15.44, revenue of €7.77M misses by $0.13MN/A
2022-03-03 04:55 ESTNewsAscendis Pharma stock falls 7% despite Q4 bottom line beatN/A
2022-03-03 04:55 ESTNewsAscendis Pharma A/S' (ASND) CEO Jan Mikkelsen on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 18:03 ESTNewsAscendis Pharma FY Earnings PreviewN/A
2022-01-25 06:13 ESTNewsPfizer/OPKO loss on somatrogon could boost Ascendis Pharma's fortunesN/A
2022-01-24 14:23 ESTNewsAscendis Pharma (ASND) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-24 14:23 ESTNewsPfizer/OPKO loss on somatragon could boost Ascendis Pharma's fortunesN/A
2022-01-14 01:12 ESTNewsAscendis Pharma's TransCon gets EU approval for growth hormone deficiency in childrenN/A
2021-12-30 05:41 ESTNewsAscendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-MakersN/A
2021-11-19 04:06 ESTNewsPhase 2 data shows durable response of Ascendis candidate for hypoparathyroidismN/A

About Ascendis Pharma A/S (ASND):

Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

See Advanced Chart

General

  • Name Ascendis Pharma A/S
  • Symbol ASND
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 482
  • Fiscal Year EndDecember
  • IPO Date2015-01-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ascendispharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 917.83
  • Price/Book (Most Recent Quarter) 8.08
  • Enterprise Value Revenue 1052.08
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$8.67
  • Next Year EPS Estimate -$7.26
  • Next Quarter EPS Estimate -$2.01
  • Return on Assets -25%
  • Return on Equity -58%
  • Earnings Per Share -$5.09
  • Revenue Per Share $0
  • Gross Profit 6.95 million
  • Quarterly Earnings Growth -78.7%
View More

Highlights

  • Market Capitalization 7.87 billion
  • Analyst Target Price $194.63
  • Book Value Per Share $8.43
View More

Share Statistics

  • Shares Outstanding 53.75 million
  • Shares Float 43.76 million
  • % Held by Insiders 3%
  • % Held by Institutions 101.6%
  • Shares Short 2.48 million
  • Shares Short Prior Month 2.21 million
  • Short Ratio 11.66
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.79
  • 52 Week High $183.98
  • 52 Week Low $96.24
  • 50 Day Moving Average 152.16
  • 200 Day Moving Average 158.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ascendis Pharma A/S (ASND) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ascendis Pharma A/S (ASND) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$535000-$3.15-$1.87-68.17%
2020-09-302020-11-11$2.76 million-$2.72-$1.87-45.17%
2020-06-302020-08-27$1.44 million-$2.33-$1.61-44.68%
2020-03-312020-05-19$2.23 million-$1.44-$1.41-2.66%
2019-12-312019-12-31$2.51 million-$1.89-$1.62-16.67%
2019-09-302019-11-18$2.44 million-$0.59-$1.2954.34%
2019-06-302019-08-28$3.62 million-$1.38-$1.33-4.4%
2019-03-312019-05-30$6.07 million-$1.38-$1.14-20.89%
2018-12-312018-12-31$12.06 million-$0.86-$1.1424.56%
2018-09-302018-11-28$23153.51-$0.92-$1.1922.87%
2018-06-302018-08-29$20949.72-$0.64-$1.0035.45%
2018-03-312018-05-30$34444.58-$1.25-$0.88-41.8%
2017-12-312018-03-28$362000-$1.13-$0.99-14.12%
2017-09-302017-11-16$546000-$1.22-$0.86-42.4%
2017-06-302017-08-18$533000-$1.11-$0.88-26.09%
2017-03-312017-05-23$398000-$0.87-$0.76-15.03%
2016-12-312017-03-22$855000-$0.55-$0.7122.7%
2016-09-302016-11-30$1.36 million-$0.76-$0.64-19.56%
2016-06-302016-08-31$1.21 million-$0.59-$0.658.96%
2016-03-312016-04-14$1.43 million-$0.59-$0.30-95.13%
2015-09-302015-11-12$2.37 million-$0.29-$0.5648.21%
2015-06-302015-08-24$2.25 million-$0.63-$0.43-46.51%
2015-03-312015-05-18$2.24 million$0.07-$0.39117.95%
2014-12-312015-01-28$2.83 million-$0.65

Ascendis Pharma A/S (ASND) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ascendis Pharma A/S (ASND) Chart:

Ascendis Pharma A/S (ASND) News:

Below you will find a list of latest news for Ascendis Pharma A/S (ASND) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ascendis Pharma A/S (ASND) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-08-151200CALL0 082.19TRUE00
2025-08-151250CALL0 079.15TRUE00
2025-08-151300CALL0 076.77TRUE00
2025-08-151350CALL0 075.83TRUE00
2025-08-1514035.83CALL0 2072.02TRUE00
2025-08-1514531.33CALL0 2068.97TRUE00
2025-08-1515023.55CALL0 1168.2TRUE00
2025-08-1515517.84CALL1 267.64TRUE17.840
2025-08-1516015.39CALL0 2164.79TRUE00
2025-08-1516512.2CALL0 262.31TRUE00
2025-08-1517013.15CALL0 262.5FALSE00
2025-08-151756CALL12 13357.15FALSE-2.54-0.3
2025-08-151805.4CALL4 3463.93FALSE5.40
2025-08-151853.6CALL1 6160.22FALSE3.60
2025-08-151904CALL27 5171.72FALSE-0.08-0.02
2025-08-151951.8CALL2 259.43FALSE1.80
2025-08-152001.5CALL1 1362.42FALSE1.50
2025-08-152101.29CALL1 471.17FALSE0.160.14
2025-08-152200.8CALL1 273.17FALSE0.80
2025-08-152300CALL0 087.48FALSE00
2025-08-152400CALL0 096.2FALSE00
2025-08-152500CALL0 0104.37FALSE00
2025-08-152600CALL0 0112.07FALSE00
2025-08-151200PUT0 0101.08FALSE00
2025-08-151250PUT0 093.06FALSE00
2025-08-151300PUT0 086.2FALSE00
2025-08-151350PUT0 072.49FALSE00
2025-08-151401.5PUT0 579.42FALSE00
2025-08-151452.15PUT0 2066.68FALSE00
2025-08-151503.1PUT0 467.26FALSE00
2025-08-151555.4PUT1 870.54FALSE10.23
2025-08-151606PUT0 22263.98FALSE00
2025-08-151658.9PUT0 152861.26FALSE00
2025-08-1517010.2PUT0 3559.89TRUE00
2025-08-1517510.6PUT0 460.39TRUE00
2025-08-151800PUT0 059.34TRUE00
2025-08-151850PUT0 056.95TRUE00
2025-08-151900PUT0 055.67TRUE00
2025-08-1519522.9PUT0 155.01TRUE00
2025-08-152000PUT0 051.4TRUE00
2025-08-1521035.3PUT0 055.6TRUE00
2025-08-152200PUT0 095.54TRUE00
2025-08-152300PUT0 0104.84TRUE00
2025-08-152400PUT0 0115.95TRUE00
2025-08-152500PUT0 0125.16TRUE00
2025-08-152600PUT0 0133.84TRUE00
2025-09-19750CALL0 0100.02TRUE00
2025-09-19800CALL0 088.26TRUE00
2025-09-19850CALL0 085.14TRUE00
2025-09-19900CALL0 079.45TRUE00
2025-09-19950CALL0 075.78TRUE00
2025-09-191000CALL0 068.67TRUE00
2025-09-191050CALL0 068.91TRUE00
2025-09-191100CALL0 066.46TRUE00
2025-09-191150CALL0 065.64TRUE00
2025-09-191200CALL0 066.49TRUE00
2025-09-191250CALL0 061.36TRUE00
2025-09-191300CALL0 062.08TRUE00
2025-09-191350CALL0 060.57TRUE00
2025-09-1914035.5CALL0 161.38TRUE00
2025-09-191450CALL0 061.28TRUE00
2025-09-1915028CALL0 159.57TRUE00
2025-09-1915524.55CALL0 158.93TRUE00
2025-09-1916019.54CALL1 059.07TRUE19.540
2025-09-1916522.6CALL0 156.25TRUE00
2025-09-1917020CALL0 26255.19FALSE00
2025-09-1917513.05CALL0 554.47FALSE00
2025-09-1918010.6CALL0 3351.33FALSE00
2025-09-1918512CALL0 39654.76FALSE00
2025-09-191906.7CALL0 954.12FALSE00
2025-09-191958.45CALL0 152.49FALSE00
2025-09-192007.2CALL0 56854.95FALSE00
2025-09-192103.2CALL0 051.75FALSE00
2025-09-192200CALL0 053.71FALSE00
2025-09-192301.95CALL0 256.4FALSE00
2025-09-192401.2CALL0 50059.93FALSE00
2025-09-192500.8CALL0 163.89FALSE00
2025-09-192600.35CALL0 167.7FALSE00
2025-09-19750PUT0 0125.63FALSE00
2025-09-19800PUT0 0116.73FALSE00
2025-09-19850PUT0 0108.38FALSE00
2025-09-19900PUT0 0100.49FALSE00
2025-09-19950PUT0 093.47FALSE00
2025-09-191000PUT0 087.16FALSE00
2025-09-191050PUT0 081.06FALSE00
2025-09-191100PUT0 075.81FALSE00
2025-09-191150PUT0 071.21FALSE00
2025-09-191200PUT0 067.04FALSE00
2025-09-191251.85PUT1 062.65FALSE1.850
2025-09-191302.5PUT1 061.78FALSE2.50
2025-09-191352.6PUT0 158.62FALSE00
2025-09-191403.3PUT0 159.73FALSE00
2025-09-191450PUT0 058.93FALSE00
2025-09-191507PUT0 100958.95FALSE00
2025-09-191558PUT1 254.99FALSE80
2025-09-191609.2PUT0 2056.5FALSE00
2025-09-1916511PUT0 21954.98FALSE00
2025-09-1917013.1PUT0 21254.2TRUE00
2025-09-1917518.44PUT0 253.7TRUE00
2025-09-1918016.5PUT0 1353.73TRUE00
2025-09-1918520.4PUT0 352.13TRUE00
2025-09-1919022.8PUT0 151.3TRUE00
2025-09-191950PUT0 051.5TRUE00
2025-09-192000PUT0 051TRUE00
2025-09-192100PUT0 050.11TRUE00
2025-09-192200PUT0 048.95TRUE00
2025-09-192300PUT0 048.6TRUE00
2025-09-192400PUT0 073.24TRUE00
2025-09-192500PUT0 079.84TRUE00
2025-09-192600PUT0 085.34TRUE00
2025-10-17750CALL0 081.76TRUE00
2025-10-17800CALL0 077.71TRUE00
2025-10-17850CALL0 072.02TRUE00
2025-10-17900CALL0 068.15TRUE00
2025-10-17950CALL0 065.45TRUE00
2025-10-171000CALL0 063.37TRUE00
2025-10-171050CALL0 060.76TRUE00
2025-10-171100CALL0 060.93TRUE00
2025-10-171150CALL0 059.35TRUE00
2025-10-171200CALL0 059.16TRUE00
2025-10-171250CALL0 058.29TRUE00
2025-10-171300CALL0 056.04TRUE00
2025-10-171350CALL0 056.15TRUE00
2025-10-171400CALL0 055.96TRUE00
2025-10-171450CALL0 055.51TRUE00
2025-10-171500CALL0 055.39TRUE00
2025-10-1715529.75CALL0 754.45TRUE00
2025-10-171600CALL0 053.82TRUE00
2025-10-171650CALL0 053.12TRUE00
2025-10-1717021.5CALL0 652.17FALSE00
2025-10-171750CALL0 051.79FALSE00
2025-10-1718013.8CALL0 351.65FALSE00
2025-10-1718512.8CALL0 150.68FALSE00
2025-10-171909.5CALL8 253.33FALSE-0.5-0.05
2025-10-171957.5CALL0 1049.5FALSE00
2025-10-172006.21CALL2 29650.23FALSE-0.81-0.12
2025-10-172104.6CALL0 147.87FALSE00
2025-10-172200CALL0 246.85FALSE00
2025-10-172300CALL0 247.33FALSE00
2025-10-172402.3CALL0 249.66FALSE00
2025-10-172501.55CALL0 152.13FALSE00
2025-10-172601.05CALL0 255.04FALSE00
2025-10-17750PUT0 0102.62FALSE00
2025-10-17800PUT0 095.38FALSE00
2025-10-17850PUT0 088.57FALSE00
2025-10-17900PUT0 082.55FALSE00
2025-10-17950PUT0 077.17FALSE00
2025-10-171000PUT0 071.98FALSE00
2025-10-171050PUT0 167.57FALSE00
2025-10-171100PUT0 163.73FALSE00
2025-10-171150PUT0 060.28FALSE00
2025-10-171201.85PUT1 056.68FALSE1.850
2025-10-171252.45PUT1 255.83FALSE2.450
2025-10-171300PUT0 255.65FALSE00
2025-10-171356PUT0 155.65FALSE00
2025-10-171400PUT0 055.36FALSE00
2025-10-171450PUT0 054.92FALSE00
2025-10-171500PUT0 052.92FALSE00
2025-10-171550PUT0 053.31FALSE00
2025-10-171600PUT0 051.68FALSE00
2025-10-171650PUT0 051.13FALSE00
2025-10-171700PUT0 050.14TRUE00
2025-10-1717517.25PUT0 049.65TRUE00
2025-10-171800PUT0 049.53TRUE00
2025-10-171850PUT0 049.01TRUE00
2025-10-171900PUT0 049.79TRUE00
2025-10-171950PUT0 048.34TRUE00
2025-10-172000PUT0 047.34TRUE00
2025-10-172100PUT0 045.58TRUE00
2025-10-172200PUT0 045.25TRUE00
2025-10-172300PUT0 042.36TRUE00
2025-10-1724070PUT0 062.49TRUE00
2025-10-172500PUT0 067.39TRUE00
2025-10-172600PUT0 072.02TRUE00
2025-12-19600CALL0 077.31TRUE00
2025-12-19650CALL0 073.95TRUE00
2025-12-19700CALL0 067.48TRUE00
2025-12-19750CALL0 165.8TRUE00
2025-12-19800CALL0 063.59TRUE00
2025-12-19850CALL0 061.91TRUE00
2025-12-19900CALL0 061.12TRUE00
2025-12-19950CALL0 060.67TRUE00
2025-12-191000CALL0 061.13TRUE00
2025-12-191050CALL0 060.92TRUE00
2025-12-191100CALL0 060.27TRUE00
2025-12-191150CALL0 059.3TRUE00
2025-12-191200CALL0 058.75TRUE00
2025-12-191250CALL0 3857.87TRUE00
2025-12-191300CALL0 157.8TRUE00
2025-12-191350CALL0 157.66TRUE00
2025-12-191400CALL0 356.84TRUE00
2025-12-1914545.54CALL0 256.75TRUE00
2025-12-1915037.5CALL0 255.63TRUE00
2025-12-191550CALL0 055.32TRUE00
2025-12-191600CALL0 6654.45TRUE00
2025-12-191650CALL0 053.57TRUE00
2025-12-1917024.2CALL0 7253.4FALSE00
2025-12-1917526CALL0 552.82FALSE00
2025-12-1918022.49CALL0 1251.88FALSE00
2025-12-1918521.7CALL0 2052.34FALSE00
2025-12-1919020.5CALL0 551.97FALSE00
2025-12-1919516.6CALL0 6051.87FALSE00
2025-12-1920018CALL0 5551.56FALSE00
2025-12-1921014.2CALL0 1150.2FALSE00
2025-12-192207.5CALL0 6650.89FALSE00
2025-12-192300CALL0 050.27FALSE00
2025-12-192408.7CALL0 250.25FALSE00
2025-12-192503.2CALL0 448.47FALSE00
2025-12-192602.4CALL0 250.05FALSE00
2025-12-19600PUT0 096.95FALSE00
2025-12-19650PUT0 190.13FALSE00
2025-12-19700PUT0 084.22FALSE00
2025-12-19750PUT0 079.06FALSE00
2025-12-19800PUT0 2074.19FALSE00
2025-12-19850PUT0 170.15FALSE00
2025-12-19900PUT0 2166.49FALSE00
2025-12-19950PUT0 163.34FALSE00
2025-12-191000PUT0 158.66FALSE00
2025-12-191052.3PUT1 159.47FALSE2.30
2025-12-191101.8PUT0 357.26FALSE00
2025-12-191152.5PUT0 157.5FALSE00
2025-12-191203.4PUT0 357.31FALSE00
2025-12-191250PUT0 156.28FALSE00
2025-12-191300PUT0 157.01FALSE00
2025-12-191350PUT0 157.01FALSE00
2025-12-191400PUT0 056.29FALSE00
2025-12-191450PUT0 156.14FALSE00
2025-12-191500PUT0 055.78FALSE00
2025-12-191550PUT0 054.71FALSE00
2025-12-191600PUT0 053.75FALSE00
2025-12-191650PUT0 052.89FALSE00
2025-12-1917018.7PUT0 11052TRUE00
2025-12-191750PUT0 051.9TRUE00
2025-12-191800PUT0 051.03TRUE00
2025-12-1918527.5PUT0 16650.84TRUE00
2025-12-191900PUT0 050.62TRUE00
2025-12-191950PUT0 050.53TRUE00
2025-12-192000PUT0 1650.32TRUE00
2025-12-192100PUT0 149.21TRUE00
2025-12-1922051.9PUT0 349.2TRUE00
2025-12-192300PUT0 048.13TRUE00
2025-12-192400PUT0 146.99TRUE00
2025-12-192500PUT0 046.85TRUE00
2025-12-1926086PUT0 146.62TRUE00
2026-01-16750CALL0 063.7TRUE00
2026-01-16800CALL0 060.86TRUE00
2026-01-16850CALL0 061.28TRUE00
2026-01-16900CALL0 059.57TRUE00
2026-01-16950CALL0 058.41TRUE00
2026-01-161000CALL0 057.87TRUE00
2026-01-161050CALL0 058.82TRUE00
2026-01-161100CALL0 057.8TRUE00
2026-01-161150CALL0 057.7TRUE00
2026-01-161200CALL0 057.21TRUE00
2026-01-161250CALL0 056.61TRUE00
2026-01-161300CALL0 056.22TRUE00
2026-01-1613545.5CALL0 155.38TRUE00
2026-01-161400CALL0 055.31TRUE00
2026-01-161450CALL0 054.39TRUE00
2026-01-1615037.5CALL0 053.76TRUE00
2026-01-161550CALL0 053.37TRUE00
2026-01-1616035.98CALL0 652.62TRUE00
2026-01-1616524.85CALL0 2152.21TRUE00
2026-01-1617029.9CALL0 851.57FALSE00
2026-01-1617525.7CALL0 651.14FALSE00
2026-01-161800CALL0 550.83FALSE00
2026-01-1618517.6CALL0 1750.42FALSE00
2026-01-1619017.9CALL0 550.24FALSE00
2026-01-1619518.9CALL0 450.21FALSE00
2026-01-1620019.05CALL0 349.9FALSE00
2026-01-1621016.16CALL0 349.25FALSE00
2026-01-162209.5CALL0 049.14FALSE00
2026-01-1623010CALL0 349.03FALSE00
2026-01-162407.2CALL0 148.3FALSE00
2026-01-162507.7CALL0 248.46FALSE00
2026-01-162600CALL0 048.26FALSE00
2026-01-16750PUT0 073.3FALSE00
2026-01-16800PUT0 069.08FALSE00
2026-01-16850PUT0 065.56FALSE00
2026-01-16900PUT0 062.34FALSE00
2026-01-16950PUT0 059.54FALSE00
2026-01-161000PUT0 056.68FALSE00
2026-01-161050PUT0 056.32FALSE00
2026-01-161100PUT0 055.21FALSE00
2026-01-161150PUT0 055.33FALSE00
2026-01-161200PUT0 055.08FALSE00
2026-01-161250PUT0 055.73FALSE00
2026-01-161300PUT0 555.71FALSE00
2026-01-161350PUT0 2753.97FALSE00
2026-01-161400PUT0 1954.5FALSE00
2026-01-161450PUT0 1453.84FALSE00
2026-01-1615018.6PUT0 153.17FALSE00
2026-01-161550PUT0 052.38FALSE00
2026-01-161600PUT0 051.59FALSE00
2026-01-1616518.6PUT0 1951.23FALSE00
2026-01-1617020.3PUT0 950.95TRUE00
2026-01-1617526.1PUT0 150.32TRUE00
2026-01-161800PUT0 050.1TRUE00
2026-01-1618527.9PUT0 549.87TRUE00
2026-01-1619032.1PUT0 249.31TRUE00
2026-01-161950PUT0 049.08TRUE00
2026-01-162000PUT0 048.88TRUE00
2026-01-162100PUT0 049.14TRUE00
2026-01-162200PUT0 048.06TRUE00
2026-01-162300PUT0 047.4TRUE00
2026-01-162400PUT0 046.86TRUE00
2026-01-162500PUT0 046.61TRUE00
2026-01-162600PUT0 047.17TRUE00
2026-06-18800CALL0 060.2TRUE00
2026-06-18850CALL0 057.93TRUE00
2026-06-18900CALL0 058.04TRUE00
2026-06-18950CALL0 057.61TRUE00
2026-06-181000CALL0 056.8TRUE00
2026-06-181050CALL0 056.54TRUE00
2026-06-181100CALL0 055.92TRUE00
2026-06-181150CALL0 055.58TRUE00
2026-06-181200CALL0 055.2TRUE00
2026-06-181250CALL0 055.61TRUE00
2026-06-181300CALL0 054.55TRUE00
2026-06-181350CALL0 054.38TRUE00
2026-06-181400CALL0 1053.96TRUE00
2026-06-181450CALL0 053.32TRUE00
2026-06-181500CALL0 052.96TRUE00
2026-06-1815551.5CALL0 252.39TRUE00
2026-06-1816049CALL0 252.07TRUE00
2026-06-1816536.9CALL0 251.57TRUE00
2026-06-1817037CALL0 1050.89FALSE00
2026-06-1817532.24CALL0 150.87FALSE00
2026-06-1818030CALL10 051.46FALSE300
2026-06-1818531.8CALL0 150.05FALSE00
2026-06-1819025.6CALL1 449.93FALSE-0.2-0.01
2026-06-181950CALL0 049.57FALSE00
2026-06-1820025.8CALL0 349.05FALSE00
2026-06-1821024.9CALL0 248.4FALSE00
2026-06-1822021.8CALL0 147.51FALSE00
2026-06-1823018.6CALL0 447.34FALSE00
2026-06-182400CALL0 046.87FALSE00
2026-06-1825013.5CALL0 146.1FALSE00
2026-06-182600CALL0 045.74FALSE00
2026-06-18800PUT0 058.3FALSE00
2026-06-18850PUT0 056.15FALSE00
2026-06-18900PUT0 056.31FALSE00
2026-06-18950PUT0 055.46FALSE00
2026-06-181000PUT0 055.45FALSE00
2026-06-181050PUT0 055.07FALSE00
2026-06-181100PUT0 054.8FALSE00
2026-06-181150PUT0 054.74FALSE00
2026-06-181200PUT0 054.58FALSE00
2026-06-181250PUT0 054.22FALSE00
2026-06-181300PUT0 254.15FALSE00
2026-06-181350PUT0 053.68FALSE00
2026-06-181400PUT0 052.89FALSE00
2026-06-181450PUT0 052.57FALSE00
2026-06-181500PUT0 052.03FALSE00
2026-06-1815522.5PUT0 152.25FALSE00
2026-06-181600PUT0 051.21FALSE00
2026-06-181650PUT0 050.92FALSE00
2026-06-181700PUT0 049.12TRUE00
2026-06-1817532.1PUT2 4049.12TRUE32.10
2026-06-1818033.3PUT0 949.65TRUE00
2026-06-1818536.1PUT0 649.5TRUE00
2026-06-181900PUT0 049.09TRUE00
2026-06-181950PUT0 048.91TRUE00
2026-06-1820044.5PUT0 248.56TRUE00
2026-06-182100PUT0 048.2TRUE00
2026-06-182200PUT0 048TRUE00
2026-06-182300PUT0 047.22TRUE00
2026-06-182400PUT0 046.64TRUE00
2026-06-182500PUT0 046.49TRUE00
2026-06-1826090.48PUT0 26946.9TRUE00

Latest ASND Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$79.93
Jun 13, 2022 7:59 PM EST4$79.91
Jun 13, 2022 7:59 PM EST118$79.93
Jun 13, 2022 7:59 PM EST9$79.97
Jun 13, 2022 7:59 PM EST17$79.97

Ascendis Pharma A/S (ASND) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025519002847/0000080255-19-002847-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025520001284/0000080255-20-001284-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000031506620000822/0000315066-20-000822-index.htm
2019-03-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000203/0000947871-19-000203-index.htm
2019-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000594/0000947871-19-000594-index.htm
2020-03-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000185/0000947871-20-000185-index.htm
2020-05-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000446/0000947871-20-000446-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000511/0000947871-20-000511-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021751/0001104659-20-021751-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021912/0001104659-20-021912-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920103962/0001104659-20-103962-index.htm
2019-02-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519042416/0001193125-19-042416-index.htm
2019-03-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519059442/0001193125-19-059442-index.htm
2019-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519061604/0001193125-19-061604-index.htm
2019-03-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519062499/0001193125-19-062499-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519065750/0001193125-19-065750-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519069120/0001193125-19-069120-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519074983/0001193125-19-074983-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096618/0001193125-19-096618-index.htm
2019-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096759/0001193125-19-096759-index.htm
2019-04-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519105316/0001193125-19-105316-index.htm
2019-04-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519112380/0001193125-19-112380-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519133019/0001193125-19-133019-index.htm
2019-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519149447/0001193125-19-149447-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161327/0001193125-19-161327-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161365/0001193125-19-161365-index.htm
2019-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519173846/0001193125-19-173846-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519175289/0001193125-19-175289-index.htm
2019-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519181943/0001193125-19-181943-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519187411/0001193125-19-187411-index.htm
2019-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519191873/0001193125-19-191873-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519196527/0001193125-19-196527-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519221217/0001193125-19-221217-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519232458/0001193125-19-232458-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519244911/0001193125-19-244911-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519255970/0001193125-19-255970-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519263919/0001193125-19-263919-index.htm
2019-10-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519265843/0001193125-19-265843-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519292336/0001193125-19-292336-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519293431/0001193125-19-293431-index.htm
2019-11-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519294735/0001193125-19-294735-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519312728/0001193125-19-312728-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520002169/0001193125-20-002169-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520005786/0001193125-20-005786-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520008093/0001193125-20-008093-index.htm
2020-02-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520033240/0001193125-20-033240-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520071551/0001193125-20-071551-index.htm
2020-03-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520092940/0001193125-20-092940-index.htm
2020-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520094591/0001193125-20-094591-index.htm
2020-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520096870/0001193125-20-096870-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520108208/0001193125-20-108208-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520111593/0001193125-20-111593-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520112279/0001193125-20-112279-index.htm
2020-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520126717/0001193125-20-126717-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520133706/0001193125-20-133706-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520142982/0001193125-20-142982-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520146167/0001193125-20-146167-index.htm
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520157336/0001193125-20-157336-index.htm
2020-06-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520167815/0001193125-20-167815-index.htm
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520180048/0001193125-20-180048-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187456/0001193125-20-187456-index.htm
2020-07-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187810/0001193125-20-187810-index.htm
2020-07-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520190428/0001193125-20-190428-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520191149/0001193125-20-191149-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520194325/0001193125-20-194325-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520219118/0001193125-20-219118-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520233148/0001193125-20-233148-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520241091/0001193125-20-241091-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520243078/0001193125-20-243078-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520252366/0001193125-20-252366-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257235/0001193125-20-257235-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257292/0001193125-20-257292-index.htm
2020-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520263856/0001193125-20-263856-index.htm
2020-10-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000119312520265872/0001193125-20-265872-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520270385/0001193125-20-270385-index.htm
2020-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520275018/0001193125-20-275018-index.htm
2019-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000121390019020915/0001213900-19-020915-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999719000498/9999999997-19-000498-index.htm
2020-07-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999720004106/9999999997-20-004106-index.htm